This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by White, T.
Right arrow Articles by Nettleman, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, T.
Right arrow Articles by Nettleman, M. D.
Related Collections
Right arrow Infectious Disease & Immunity

PEDIATRICS Vol. 103 No. 6 June 1999, p. e73

ELECTRONIC ARTICLE:
Potential Cost Savings Attributable to Influenza Vaccination of School-aged Children

Received Oct 26, 1998; accepted Jan 25, 1999.

Terry White*, Suzanne Lavoie*, Dagger , and Mary D. Nettleman*

From the Departments of * Internal Medicine and Dagger  Pediatrics, Virginia Commonwealth University School of Medicine, Richmond, Virginia.

Objective.  To analyze the costs and benefits of influenza vaccination of healthy school-aged children.

Design.  The analysis was based on data from the literature. Total costs included direct medical costs for vaccination, physician visits, and treatment as well as indirect costs. Indirect costs were in the form of lost productivity when working parents stayed home to care for ill children or to take children to an office for vaccination. The total costs of vaccination strategies were compared with the total cost of not vaccinating. For the base case, the vaccine was assumed to have no effect on rates of otitis media.

Setting.  Two hypothetical scenarios were investigated 1) individual-initiated vaccination and 2) vaccination in a group-based setting. The former scenario required the child to be accompanied to a clinic by a parent during usual work hours.

Results.  Vaccination resulted in a net savings per child vaccinated of $4 for individual-initiated vaccination and of $35 for group-based vaccination. The savings were caused primarily by averted indirect costs. Moderate increases in the cost of vaccination or reductions in the rate of influenza would eliminate the savings for individual-initiated vaccination but not for group-based vaccination. Alternatively, if influenza vaccination was effective in reducing rates of otitis media, the net savings from vaccination would be substantially higher than the base case.

Conclusion.  Vaccination of school-aged children against influenza could have substantial financial benefits to society, especially if performed in a group-based setting. influenza, cost-effectiveness, vaccination, children, cost. .




This article has been cited by other articles:


Home page
 Arch Pediatr Adolesc MedHome page
R. M. Ferdman and J. A. Church
Denial of insurance authorization at a subspecialty office as a cause of missed opportunities for influenza vaccination in children with asthma.
Arch Pediatr Adolesc Med, September 1, 2006; 160(9): 987 - 988.
[Full Text] [PDF]

Home page
 Am J EpidemiolHome page
J. S. Brownstein, K. P. Kleinman, and K. D. Mandl
Identifying Pediatric Age Groups for Influenza Vaccination Using a Real-Time Regional Surveillance System
Am. J. Epidemiol., October 1, 2005; 162(7): 686 - 693.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
N Principi, S Esposito, R Gasparini, P Marchisio, P Crovari, and for the Flu-Flu Study Group*
Burden of influenza in healthy children and their households
Arch. Dis. Child., November 1, 2004; 89(11): 1002 - 1007.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
M. J. Gaglani and G. B. Herschler
Every Nose Counts: A New Influenza Vaccine for All Healthy Schoolchildren?
Clinical Pediatrics, January 1, 2004; 43(1): 35 - 41.
[Abstract] [PDF]